Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1369 studies found for:    "Retinoschisis" OR "Retinal Degeneration" OR "X-linked juvenile retinoschisis"
Show Display Options
Rank Status Study
21 Recruiting Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)
Conditions: Inherited Ophthalmic Diseases;   Inherited Retinal Degeneration
Intervention: Drug: Interferon gamma-1b
22 Recruiting Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma.
Conditions: Retinal Degeneration;   Primary Open-angle Glaucoma
Interventions: Procedure: Intravitreal transplantation of mesenchymal stem cell;   Biological: Culture and isolation of autologous bone-marrow mesenchymal stem cells
23 Active, not recruiting Saffron Supplementation in Stargardt's Disease
Conditions: Retinal Degeneration;   Genetic Disease;   Single-Gene Defects;   Macular Dystrophy
Interventions: Dietary Supplement: Saffron supplementation;   Other: placebo
24 Completed Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients
Conditions: Retinal Degeneration,;   Retinitis Pigmentosa
Intervention: Procedure: surgical implantation of subretinal device
25 Enrolling by invitation Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Glaucomatous Neurodegeneration
Conditions: Retinal Degeneration;   Primary Open-Angle Glaucoma
Interventions: Other: Subtenon administration of autologous ADRC;   Procedure: Liposuction;   Device: ADRC isolation
26 Recruiting Argus® II Retinal Prosthesis System Post-Market Surveillance Study
Conditions: Outer Retinal Degeneration;   Retinitis Pigmentosa
Intervention:
27 Active, not recruiting Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients
Conditions: Retinitis Pigmentosa;   Retinal Degeneration
Intervention: Device: Device name: "Retina Implant model Alpha". Surgical implantation of medical device into eye
28 Recruiting Cell Collection to Study Eye Diseases
Conditions: Retinal Disease;   AMD;   Retinal Degeneration
Intervention:
29 Recruiting Rod and Cone Mediated Function in Retinal Disease
Conditions: Retinal Degeneration;   Retinitis Pigmentosa;   Stargardt's Disease
Intervention:
30 Completed Postoperative Pain Control Following Vitreoretinal Surgery
Conditions: Retinal Detachment;   Proliferative Vitreoretinopathy;   Retinoschisis
Interventions: Drug: Triamcinolone;   Drug: Bupivicaine Hydrochloride
31 Completed
Has Results
Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration
Conditions: Age-Related Maculopathy;   Age-Related Maculopathies;   Eye Diseases;   Retinal Degeneration;   Macular Degeneration
Interventions: Biological: RN6G;   Biological: Placebo
32 Completed Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
Conditions: Healthy;   Muscular Dystrophy;   Retinal Degeneration;   Skin Diseases;   Virus Diseases
Intervention:
33 Completed Pain Perception at Laser Treatment
Condition: Laser Therapy, Low-Level
Intervention: Procedure: retina photocoagulation
34 Completed Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration
Conditions: Macular Degeneration;   Wet Macular Degeneration;   Retinal Degeneration;   Retinal Diseases;   Eye Diseases
Intervention: Drug: Aflibercept
35 Recruiting Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
Conditions: Eye Diseases;   Macular Degeneration;   Retinal Diseases;   Retinal Degeneration;   Neovascularization, Pathologic
Interventions: Drug: OPT-302;   Drug: Lucentis™
36 Completed Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy
Conditions: Age-Related Maculopathy;   Age-Related Maculopathies;   Eye Diseases;   Retinal Degeneration;   Macular Degeneration
Interventions: Biological: RN6G;   Biological: Placebo
37 Completed Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa;   Retinal Diseases;   Eye Diseases;   Eye Disease, Hereditary;   Retinal Degeneration
Intervention: Drug: Valproic Acid
38 Recruiting Inherited Retinal Degenerative Disease Registry
Conditions: Eye Diseases Hereditary;   Retinal Disease;   Achromatopsia;   Bardet-Biedl Syndrome;   Bassen-Kornzweig Syndrome;   Batten Disease;   Best Disease;   Choroidal Dystrophy;   Choroideremia;   Cone Dystrophy;   Cone-Rod Dystrophy;   Congenital Stationary Night Blindness;   Enhanced S-Cone Syndrome;   Fundus Albipunctatus;   Goldmann-Favre Syndrome;   Gyrate Atrophy;   Juvenile Macular Degeneration;   Kearns-Sayre Syndrome;   Leber Congenital Amaurosis;   Refsum Syndrome;   Retinitis Pigmentosa;   Retinitis Punctata Albescens;   Retinoschisis;   Rod-Cone Dystrophy;   Rod Dystrophy;   Rod Monochromacy;   Stargardt Disease;   Usher Syndrome
Intervention:
39 Unknown  Long-Term Efficacy in AMD of Rheopheresis in North America
Condition: Macular Degeneration
Intervention: Device: Rheopheresis blood filtration
40 Completed
Has Results
Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A
Condition: Retinitis Pigmentosa
Interventions: Drug: Lutein;   Dietary Supplement: Cornstarch control

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.